India’s drug regulator DCGI has granted permission to Mumbai-based pharmaceutical company Cipla to import Moderna’s COVID-19 vaccine for restricted emergency use in the country, official sources said on Tuesday. Moderna’s vaccine will be the fourth COVID-19 jab to be available in India after Covishield, Covaxin, and Sputnik. In separate communications, Moderna on June 27 informed DCGI that the US government has agreed to donate doses of Moderna’s vaccine through Covax to India.